|
The 2025 Fierce Pharma Marketing Awards, presented by Fierce Pharma, recognizes the most innovative and impactful campaigns that have helped improve patient outcomes and advance the industry over the last year.
Stand Out and Be Acknowledged as a Leader in the Industry
We will recognize and celebrate the individuals, teams, and companies that are leading the way in adopting innovative tools and technologies to push campaigns to the next level.
The submission deadline is approaching! Enter by June 19 to qualify. |
|
|
|
Download the Entry Kit.
Check out our easy guide to entering with important dates and deadlines, FAQs, category information and more. | Download Now |
|
|
|
- Marketer of the Year - NEW
- Best Use of AI - NEW
- Influencer-Driven Campaign - NEW
- Charitable or Philanthropic Campaign - NEW
- Agency of the Year
- Digital Campaign – Non-Social Media
- Impiricus HCP Impact Award - Free to Enter
- Medical Conference or Event Marketing
|
|
- Multicultural Campaign
- New Brand Launch
- Online Video or Film
- Podcast or Audio
- Pharma TV
- Professional Marketing
- Public Relations Campaign
- Social Media for Consumer
- Website for Consumer
|
|
|
The deadline to submit is June 19. |
|
|
|
What Finalists & Winners Receive: Receive a prestigious trophy live at the Awards Gala during Fierce Pharma Week in Philadelphia. Complimentary access to Fierce Pharma Week (Sept 8–11) and Gala (Sept 10)—a $3,000+ value. One-year rights to use the 2025 Finalist/Winner badge in marketing and PR. Featured in the official press release and on Fierce Pharma Week/Awards websites for 12 months. Customizable press release template to amplify your recognition. Social media spotlight across Fierce Pharma’s LinkedIn, X, Facebook, and Instagram channels.
|
|
|
|
2025 Key Dates & Information June 19: Submissions Deadline July 24: Finalists Announced September 10: Awards Gala
Stay up-to-date and join our mailing list! |
|
|
| Thank You to Our 2025 Partners |
|
|
|
 | IMPIRICUS HCP Impact Award |
|
 | Best Use of AI |
|
|
| Sponsor |  |
|
|
|
|
|